Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-080558

SUPERNUS PHARMACEUTICALS, INC. · SUPN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Nov 13, 2015
Accepted (ET)
Nov 17, 2015 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF5,F6Nov 13, 2015S100,000$16.2561D112,650ISee Note 6
Common StockF7,F6Nov 16, 2015S19,650$16.1341D93,000ISee Note 6
Common StockF1holding———3,820,625ISee Note 1
Common Stockholding———73,929D
Common StockF2holding———36,965ISee Note 2
Common StockF3holding———21,380ISee Note 3
Common StockF4holding———15,584ISee Note 4

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses